Evidence map›Paper›PMID 39028840›Full record

ArticleG3 (Bethesda, Md.)2024

A random mutagenesis screen enriched for missense mutations in bacterial effector proteins.

Malene L Urbanus, Thomas M Zheng, Anna N Khusnutdinova, Doreen Banh, Harley O'Connor Mount, Alind Gupta, Peter J Stogios, Alexei Savchenko, Ralph R Isberg, Alexander F Yakunin and 1 more

Abstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Malene L UrbanusDepartment of Biochemistry, University of Toronto, Toronto, ON M5G 1M1, Canada.ORCID 0009-0008-0850-3805
Thomas M ZhengDepartment of Biochemistry, University of Toronto, Toronto, ON M5G 1M1, Canada.ORCID 0009-0005-9674-5991
Anna N KhusnutdinovaDepartment of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON M5S 1A4, Canada.
Doreen BanhDepartment of Biochemistry, University of Toronto, Toronto, ON M5G 1M1, Canada.
Harley O'Connor MountDepartment of Molecular Genetics, University of Toronto, Toronto, ON M5G 1M1, Canada.ORCID 0000-0003-1401-9178
Alind GuptaDepartment of Molecular Genetics, University of Toronto, Toronto, ON M5G 1M1, Canada.
Peter J StogiosDepartment of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON M5S 1A4, Canada.ORCID 0000-0001-8663-1425
Alexei SavchenkoDepartment of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON M5S 1A4, Canada.ORCID 0000-0002-5256-9237
Ralph R IsbergDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA 02115, USA.ORCID 0000-0002-8330-3554
Alexander F YakuninDepartment of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON M5S 1A4, Canada.ORCID 0000-0003-0813-6490
Alexander W EnsmingerDepartment of Biochemistry, University of Toronto, Toronto, ON M5G 1M1, Canada.ORCID 0000-0003-0824-3704

Funding

CIHR PJT-162256NSERC Strategic Network
6 · The paper itself

Abstract

To remodel their hosts and escape immune defenses, many pathogens rely on large arsenals of proteins (effectors) that are delivered to the host cell using dedicated translocation machinery. Effectors hold significant insight into the biology of both the pathogens that encode them and the host pathways that they manipulate. One of the most powerful systems biology tools for studying effectors is the model organism, Saccharomyces cerevisiae. For many pathogens, the heterologous expression of effectors in yeast is growth inhibitory at a frequency much higher than housekeeping genes, an observation ascribed to targeting conserved eukaryotic proteins. Abrogation of yeast growth inhibition has been used to identify bacterial suppressors of effector activity, host targets, and functional residues and domains within effector proteins. We present here a yeast-based method for enriching for informative, in-frame, missense mutations in a pool of random effector mutants. We benchmark this approach against three effectors from Legionella pneumophila, an intracellular bacterial pathogen that injects a staggering >330 effectors into the host cell. For each protein, we show how in silico protein modeling (AlphaFold2) and missense-directed mutagenesis can be combined to reveal important structural features within effectors. We identify known active site residues within the metalloprotease RavK, the putative active site in SdbB, and previously unidentified functional motifs within the C-terminal domain of SdbA. We show that this domain has structural similarity with glycosyltransferases and exhibits in vitro activity consistent with this predicted function.

Indexed as

Bacterial ProteinsLegionella pneumophilaMutagenesisMutation, MissenseSaccharomyces cerevisiaeModels, MolecularBacterial ProteinsAlphaFoldbacterial effectorLegionella pneumophilaloss-of-function mutantmissense mutationrandom mutagenesis screenSaccharomyces cerevisiae

Identifiers

PMID39028840
PMCPMC11373652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.